United States - English - NLM (National Library of Medicine)

aralez pharmaceuticals us inc. - vorapaxar sulfate (unii: in66038e6c) (vorapaxar - unii:zce93644n2) - vorapaxar 2.08 mg - zontivity ® is indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction (mi) or with peripheral arterial disease (pad). zontivity has been shown to reduce the rate of a combined endpoint of cardiovascular death, mi, stroke, and urgent coronary revascularization (ucr). zontivity is contraindicated in patients with a history of stroke, tia, or ich because of an increased risk of ich in this population [see adverse reactions (6)] . discontinue zontivity in patients who experience a stroke, tia, or ich [see adverse reactions (6.1) and clinical studies (14)] . zontivity is contraindicated in patients with active pathological bleeding such as ich or peptic ulcer [see warnings and precautions (5.1) and adverse reactions (6.1)] . risk summary based on the potenti

United States - English - NLM (National Library of Medicine)

aralez pharmaceuticals us inc. - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), omeprazole (unii: kg60484qx9) (omeprazole - unii:kg60484qx9) - aspirin 81 mg - yosprala, a combination of aspirin and omeprazole, is indicated for patients who require aspirin for secondary prevention of cardiovascular and cerebrovascular events and who are at risk of developing aspirin associated gastric ulcers. the aspirin component of yosprala is indicated for: - reducing the combined risk of death and nonfatal stroke in patients who have had ischemic stroke or transient ischemia of the brain due to fibrin platelet emboli, - reducing the combined risk of death and nonfatal mi in patients with a previous mi or unstable angina pectoris, - reducing the combined risk of mi and sudden death in patients with chronic stable angina pectoris, - use in patients who have undergone revascularization procedures (coronary artery bypass graft [cabg] or percutaneous transluminal coronary angioplasty [ptca]) when there is a pre-existing condition for which aspirin is already indicated. the omeprazole component of yosprala is indicated for decreasing the risk of developing aspirin-associated gastric u

Canada - English - Health Canada

aralez pharmaceuticals canada inc - acetylsalicylic acid; caffeine; butalbital; codeine phosphate - capsule - 330mg; 40mg; 50mg; 15mg - acetylsalicylic acid 330mg; caffeine 40mg; butalbital 50mg; codeine phosphate 15mg - opiate agonists

Canada - English - Health Canada

aralez pharmaceuticals canada inc - diclofenac potassium - powder for solution - 50mg - diclofenac potassium 50mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

aralez pharmaceuticals canada inc - butalbital; caffeine; acetylsalicylic acid - capsule - 50mg; 40mg; 330mg - butalbital 50mg; caffeine 40mg; acetylsalicylic acid 330mg - barbiturates

Canada - English - Health Canada

aralez pharmaceuticals canada inc - sumatriptan (sumatriptan succinate); naproxen sodium - tablet - 85mg; 500mg - sumatriptan (sumatriptan succinate) 85mg; naproxen sodium 500mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

aralez pharmaceuticals canada inc - bilastine - tablet - 20mg - bilastine 20mg - second generation antihistamines

Canada - English - Health Canada

aralez pharmaceuticals canada inc - bilastine - solution - 2.5mg - bilastine 2.5mg - second generation antihistamines

Canada - English - Health Canada

aralez pharmaceuticals canada inc - bilastine - tablet (orally disintegrating) - 10mg - bilastine 10mg - second generation antihistamines

Canada - English - Health Canada

aralez pharmaceuticals canada inc - polyethylene glycol 3350; sodium sulfate anhydrous; sodium chloride; potassium chloride; sodium ascorbate; ascorbic acid - powder for solution - 100g; 7.5g; 2.691g; 1.015g; 5.9g; 4.7g - polyethylene glycol 3350 100g; sodium sulfate anhydrous 7.5g; sodium chloride 2.691g; potassium chloride 1.015g; sodium ascorbate 5.9g; ascorbic acid 4.7g - cathartics and laxatives